Spontaneous choroidal hemorrhage in a patient on dabigatran etexilate (Pradaxa).
OBJECTIVE
To report the first known case of spontaneous choroidals in association with a patient on dabigatran etexilate.


METHODS
Observational case report.


RESULTS
An 82-year-old man on 150 mg dabigatran etexilate by mouth twice a day for atrial fibrillation developed spontaneous choroidal hemorrhage in his left eye. No other causes were found after careful history and examination.


CONCLUSIONS
Dabigatran is a popular new alternative to warfarin that has no blood monitoring or reversal agent. Physicians should be aware of this new medication and its possible hemorrhagic complications.
*Department of Ophthalmology, University of Missouri-Kansas City, Kansas City, Missouri; and †Retina Associates of Southern Utah, St. George, Utah.
Terry S
TS
Kang
Ken
K
Lord
Nancy
N
Kunjukunju
D000369:Aged, 80 and over; D001562:Benzimidazoles / Q000009:adverse effects*; D002832:Choroid Hemorrhage / Q000139:chemically induced*; D000069604:Dabigatran; D065427:Factor Xa Inhibitors / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011725:Pyridines / Q000009:adverse effects*
D001562:Benzimidazoles; D065427:Factor Xa Inhibitors; D011725:Pyridines; D000069604:Dabigatran